pyridoxal phosphate has been researched along with amphotericin b in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Dick, GM; Koh, SD; Sanders, KM | 1 |
Evans, RJ; Lewis, CJ | 1 |
Anbanandam, A; David, SA; Day, TP; Day, VW; Shukla, NM; Sil, D | 1 |
4 other study(ies) available for pyridoxal phosphate and amphotericin b
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Small-conductance Ca(2+)-dependent K+ channels activated by ATP in murine colonic smooth muscle.
Topics: Adenosine Triphosphate; Amphotericin B; Animals; Apamin; Cells, Cultured; Colon; Egtazic Acid; Female; Ion Channel Gating; Male; Membrane Potentials; Mice; Mice, Inbred BALB C; Muscle, Smooth; Potassium Channels; Potassium Channels, Calcium-Activated; Probability; Pyridoxal Phosphate; Receptors, Purinergic P2; Small-Conductance Calcium-Activated Potassium Channels; Thionucleotides; Uridine Triphosphate | 1997 |
Lack of run-down of smooth muscle P2X receptor currents recorded with the amphotericin permeabilized patch technique, physiological and pharmacological characterization of the properties of mesenteric artery P2X receptor ion channels.
Topics: Adenosine Triphosphate; Amphotericin B; Animals; Calcium; Cell Membrane Permeability; Dose-Response Relationship, Drug; Guanosine Triphosphate; Immunohistochemistry; Ion Channels; Male; Membrane Potentials; Mesenteric Arteries; Muscle, Smooth, Vascular; Patch-Clamp Techniques; Pyridoxal Phosphate; Rats; Rats, Wistar; Receptors, Purinergic P2; Receptors, Purinergic P2X; Receptors, Purinergic P2X2; Receptors, Purinergic P2X3; Receptors, Purinergic P2X4; Receptors, Purinergic P2X5; Receptors, Purinergic P2X7; Suramin; Thionucleotides; Time Factors | 2000 |
Imbuing aqueous solubility to amphotericin B and nystatin with a vitamin.
Topics: Amphotericin B; Nystatin; Prodrugs; Pyridoxal Phosphate; Solubility | 2011 |